Aggressive Insulin Intensification Required
With an A1c of 8.6% and only 14% time in range (TIR) with 86% high readings, you need to substantially increase both basal and prandial insulin doses immediately—this patient is severely undertreated and at risk for long-term microvascular complications. 1
Immediate Action Plan
Step 1: Optimize Basal Insulin (Basaglar) First
The CGM data showing 86% high readings indicates inadequate basal coverage. Your priority is achieving fasting plasma glucose (FPG) control:
- Increase Basaglar by 10-20% immediately (or 4 units if current dose is <40 units) 1
- Titrate upward by 2 units every 3 days until FPG reaches 70-130 mg/dL 1
- Monitor overnight CGM patterns—if glucose rises from bedtime to morning, basal is insufficient
- Continue aggressive titration; don't stop at modest improvements
Critical pitfall: The 2025 ADA guidelines explicitly warn against "overbasalization"—but this patient is nowhere near that. Signs of overbasalization include elevated bedtime-to-morning differential, hypoglycemia, or high glucose variability 1. With 86% high readings, you're far from this concern.
Step 2: Intensify Prandial Insulin (Humalog U200)
Once FPG approaches target (or simultaneously if A1c >8% as in this case), aggressively address postprandial hyperglycemia:
If patient is already on prandial insulin:
- Increase each meal dose by 10-15% (or 1-2 units per injection) 1
- Focus first on the meal causing the largest glucose excursion per CGM data
- Titrate every 3-5 days based on 2-hour postprandial readings
If starting prandial insulin:
- Begin with 4 units before the largest meal OR 10% of current basal dose 1
- Add second meal dose within 1-2 weeks if A1c remains >7.5%
- Progress to full basal-bolus (three meal doses) if needed
Step 3: Reassess in 3-6 Months Maximum
The 2025 guidelines emphasize avoiding therapeutic inertia by reassessing every 3-6 months 1. With this degree of hyperglycemia, schedule follow-up in 6-8 weeks to review CGM data and adjust further.
Dosing Specifics
Basal insulin adjustments:
- If A1c >8% (as here): Increase by 10-20% or 4 units, whichever is greater 1
- Continue titrating 2 units every 3 days until FPG <130 mg/dL 1
- For hypoglycemia: Reduce by 10-20% and identify cause 1
Prandial insulin adjustments:
- Start: 4 units or 10% of basal dose 1
- Titrate: Increase by 1-2 units or 10-15% every 3-5 days 1
- If A1c <8%, consider reducing basal by 4 units when adding prandial to prevent hypoglycemia 1—but this patient's A1c is 8.6%, so maintain or increase basal
Additional Considerations
Consider GLP-1 RA addition: If not already prescribed, adding a GLP-1 receptor agonist or dual GIP/GLP-1 RA can improve glycemic control while reducing insulin requirements and weight gain 1. This is particularly relevant given the magnitude of hyperglycemia.
Glucagon prescription: Ensure patient has glucagon available as insulin doses increase 1
CGM utilization: The 14% TIR is critically low (target >70%). Use the ambulatory glucose profile to identify specific timing of hyperglycemia—overnight highs suggest basal insufficiency, postprandial spikes indicate inadequate prandial coverage 2
Why This Aggressive Approach
Research shows that patients converting to Basaglar from other basal insulins require similar or slightly higher doses (mean increase of 2 units in type 2 diabetes) 3. The current regimen is clearly insufficient given the CGM data. The 2025 ADA guidelines explicitly state that when A1c is >8%, therapeutic inertia must be avoided through regular reassessment and modification every 3-6 months 1.
Bottom line: This patient needs immediate, substantial increases in both basal and prandial insulin. Start with 10-20% basal increase, titrate aggressively every 3 days, and simultaneously optimize prandial dosing. The goal is FPG 70-130 mg/dL and TIR >70% within 3 months.